Jon Mordal

Vestfold Hospital Trust

H指数:11

被引数:492

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The need for longer-term treatment with extended-release naltrexone: a 52-week naturalistic clinical study in patients with opioid use disorder

长期使用缓释纳曲酮治疗的必要性：一项为期52周的自然主义临床研究，研究对象为阿片类药物使用障碍患者

Substance Abuse Treatment Prevention and Policy

IF3.2

2026-10-060

Genetic Influence on Extended-Release Naltrexone Treatment Outcomes in Patients with Opioid Use Disorder: An Exploratory Study

阿片类药物使用障碍患者中基因对缓释纳曲酮治疗效果的影响：一项探索性研究

Brain Sciences 2026, Vol. 16, Page 23

IF2.8

2025-12-250

OAAI

Impact of dextroamphetamine substitution on the use of illicit amphetamines in adults with amphetamine dependence: a study protocol for the multicentre double blind randomised controlled trial ATLAS4Dependence

BMJ OPEN

IF2.3

2025-10-200

Changes in Quality of Life During 52 weeks of Extended-Release Naltrexone Treatment, subsequent by a 1-year post-treatment period

52周缓释纳曲酮治疗期间生活质量的变化，随后进入为期1年的治疗后随访期

Drug and Alcohol Dependence

IF3.6

2025-10-100

OAAI

The relationship between the brain-derived neurotrophic factor and neurocognitive response to physical exercise in individuals with schizophrenia

PSYCHONEUROENDOCRINOLOGY

IF3.6

2023-11-011

PRE

Alterations in inflammatory markers after a 12-week exercise program in individuals with schizophrenia-a randomized controlled trial

精神分裂症患者12周运动后炎症标志物的变化-一项随机对照试验

FRONTIERS IN PSYCHIATRY

IF3.2

2023-05-113

OAAI

High-intensity interval training may reduce depressive symptoms in individuals with schizophrenia, putatively through improved VO2max: A randomized controlled trial

FRONTIERS IN PSYCHIATRY

IF3.2

2022-08-0413

OAAI

Exploring low grade inflammation by soluble urokinase plasminogen activator receptor levels in schizophrenia: a sex-dependent association with depressive symptoms

BMC PSYCHIATRY

IF3.6

2021-10-265

OAAI

Elevated levels of soluble urokinase plasminogen activator receptor as a low-grade inflammation marker in schizophrenia: A case-control study

SCHIZOPHRENIA RESEARCH

IF3.5

2021-02-015

PREAI

High-intensity interval training and active video gaming improve neurocognition in schizophrenia: a randomized controlled trial

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

IF3.7

2020-11-0622

PREAI

Norwegian version of the Mini-International Neuropsychiatric Interview: Feasibility, acceptability and test-retest reliability in an acute psychiatric ward

EUROPEAN PSYCHIATRY

IF6.7

2020-04-1684

PREAI

The Association Between Cardiorespiratory Fitness and Cognition Appears Neither Related to Current Physical Activity Nor Mediated by Brain-Derived Neurotrophic Factor in a Sample of Outpatients With Schizophrenia

FRONTIERS IN PSYCHIATRY

IF3.2

2019-10-254

OAAI

Objectively Assessed Daily Steps-Not Light Intensity Physical Activity, Moderate-to-Vigorous Physical Activity and Sedentary Time-Is Associated With Cardiorespiratory Fitness in Patients With Schizophrenia

客观评估的日常步数-不是轻度的体力活动，中度至剧烈的体力活动和久坐时间-与精神分裂症患者的心肺健康相关

FRONTIERS IN PSYCHIATRY

IF3.2

2019-02-268

OAAI

A comparison of symptoms and drug use between patients with methamphetamine associated psychoses and patients diagnosed with schizophrenia in two acute psychiatric wards

PSYCHIATRY RESEARCH

IF3.9

2013-03-0150

OAAI

Drugs of abuse among acute psychiatric and medical admissions: laboratory based identification of prevalence and drug influence

GENERAL HOSPITAL PSYCHIATRY

IF3.7

2008-01-0116

OAAI

Jon Mordal

个人简介

教育背景

工作经历

荣誉奖项

研究方向